2026Co-founder· CellType (YC W26)
Founder · since 2026Company
CellType (YC W26)
Role
Co-Founder
current
Stage
—
no public source
Raised
—
no public source
Based
—
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work historyProfile coverage5 of 7 · missing posts, contact
Experience
Career
2026CellType (YC W26)
Co-founderCo-Founder · 2026 – Present
2023Yale University
Researcher, Machine Learning · United States · 2023 – Present
2023Advanced Silicon
Researcher, Machine Learning · Switzerland · 2023 – 2024
2022EPFL
Graduate Student Researcher, Machine Learning and Computer Vision · Switzerland · 2022 – 2023
2021Siemens
Software Engineer · 2021 – 2022
Bio
Co-Founder @ CellType (W26). ML @ Yale & EPFL. Building the next-generation agentic drug company. Co-developed our core technology Cell2Sentence at Yale and published at ICML. Previously led large-scale foundation model training at a biotech startup and built software to control CERN's Large Hadron Collider.